Sfoglia per AUTORE
GEORGE A
Collezione AOU Città della Salute di Torino

  

Items : 4

Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Oct;74(5):581-589. doi: 10.23736/S2724-6051.20.04160-0. Epub 2021 Jan 13.
2022
AOU Città della Salute di Torino

Marra G; Laguna MP; Walz J; Pavlovich CP; Bianco F; Gregg J; Lebastchi AH; Lepor H; Macek P; Rais-Bahrami S; Robertson C; Rukstalis D; Salomon G; Ukimura O; Abreu AL; Barbe Y; Cathelineau X; Gandaglia G; George AK; Gomez Rivas J; Gupta RT; Lawrentschuk N; Kasivisvanathan V; Lomas D; Malavaud B; Margolis D; Matsuoka Y; Mehralivand S; Moschini M; et alii...

Utilization of focal therapy for patients discontinuing active surveillance of prostate cancer: Recommendations of an international Delphi consensus. in Urologic oncology / Urol Oncol. 2021 Nov;39(11):781.e17-781.e24. doi: 10.1016/j.urolonc.2021.01.027. Epub 2021 Mar 4.
2021
AOU Città della Salute di Torino

Sidana A; Song DY; Pinto PA; Marra G; Marks LS; Lebastchi AH; Katz AE; Gupta RT; Gill IS; George AK; Feller JF; Emberton M; Carroll PR; Klotz L; Tan WP; Rastinehad AR; Ward JF; Sanchez-Salas R; Rosette J; Polascik TJ;

Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry. in European heart journal / Eur Heart J. 2019 Sep 14;40(35):2964-2975. doi: 10.1093/eurheartj/ehz311.
2019
AOU Città della Salute di Torino

Crotti L; Spazzolini C; Tester DJ; Ghidoni A; Baruteau AE; Beckmann BM; Behr ER; Bennett JS; Bezzina CR; Bhuiyan ZA; Celiker A; Cerrone M; Dagradi F; De Ferrari GM; Etheridge SP; Fatah M; Garcia-Pavia P; Al-Ghamdi S; Hamilton RM; Al-Hassnan ZN; Horie M; Jimenez-Jaimez J; Kanter RJ; Kaski JP; Kotta MC; Lahrouchi N; Makita N; Norrish G; Odland HH; et alii...

Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial. in The Lancet. Haematology / Lancet Haematol. 2019 Sep;6(9):e459-e469. doi: 10.1016/S2352-3026(19)30110-3. Epub 2019 Jul 18.
2019
AOU Città della Salute di Torino

Mateos MV; Blacklock H; Schjesvold F; Oriol A; Simpson D; George A; Goldschmidt H; Larocca A; Chanan-Khan A; Sherbenou D; Avivi I; Benyamini N; Iida S; Matsumoto M; Suzuki K; Ribrag V; Usmani SZ; Jagannath S; Ocio EM; Rodriguez-Otero P; San Miguel J; Kher U; Farooqui M; Liao J; Marinello P; Lonial S;